Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Geriatric malignancies and their hormonal aspects

G T Schneider, A Mickal

    Gerontology
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Hormonal therapy shows promise for advanced reproductive cancers, including endometrial and breast cancers. While synthetic progesterone is used for endometrial adenocarcinoma, experimental agents like dimethylprogesterone are under investigation for ovarian carcinoma.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Games in the environmental context and their strategic use for environmental education.

    Brazilian journal of biology = Revista brasleira de biologia·2015
    Same author

    Granular cell tumor of the vulva: literature review and case report.

    The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society·1996
    Same author

    Studies of stereodynamic interaction of the EEG and auditory potentials of the limbic system and non-auditory frontal cortex.

    Biomedical sciences instrumentation·1991
    Same author

    Partial (coherence & correlation) estimates of brain autorhythmicity.

    Biomedical sciences instrumentation·1991
    Same author

    A new technique to define and clarify esophageal motor disorders.

    American journal of surgery·1990
    Same author

    Autoregressive spectral filter studies on the sensorimotor rhythm EEG state variable.

    Biomedical sciences instrumentation·1990

    Area of Science:

    • Gynecologic Oncology
    • Endocrinology
    • Medical Oncology

    Background:

    • Malignant diseases of the female reproductive organs cause significant mortality in older women.
    • Hormonal therapies are increasingly used alongside conventional treatments for these cancers.
    • Synthetic progesterone aids in palliation for advanced endometrial adenocarcinoma.

    Purpose of the Study:

    • To evaluate the efficacy of hormonal therapy in advanced gynecologic and breast cancers.
    • To investigate the use of experimental progesterone agents in ovarian carcinoma.
    • To assess the response rates of breast cancer patients to hormonal therapy based on estrogen receptor status.

    Main Methods:

    • Administration of synthetic progesterone for advanced endometrial adenocarcinoma.

    Related Experiment Videos

  • Testing of a high-dose experimental progesterone agent (dimethylprogesterone) in ovarian carcinoma patients.
  • Analysis of clinical response to hormonal therapy in advanced breast cancer patients with and without estradiol receptors.

    • Main Results:

    • Synthetic progesterone use in endometrial cancer is associated with increased incidence of ovarian cortical stromal hyperplasia, obesity, diabetes, and hypertension.
    • Dimethylprogesterone is being tested in patients with advanced ovarian carcinoma who failed conventional therapy; early results show some remissions but are inconclusive.
    • Advanced breast cancer patients with estradiol receptors show a 40-60% favorable response to hormonal therapy, while those lacking receptors have a minimal chance of response.

    Conclusions:

    • Hormonal therapy, including synthetic and experimental progesterone agents, plays a role in managing advanced gynecologic malignancies.
    • Estrogen receptor status is a critical determinant of treatment response in advanced breast cancer.
    • Further research is needed to establish conclusive results for experimental agents like dimethylprogesterone in ovarian cancer.